1. Louthrenoo, W, Gumtorntip, W, Thanunchai, P, Amantakul, A, Kasitanon, N, Pojchamarnwiputh, S et al.. Clinical features, imaging findings, and outcomes of acute abdominal pain in systemic lupus erythematosus: comparing mesenteric vasculitis, non-mesenteric vasculitis, and surgical conditions. Clin Rheumatol. 2024; :. doi: 10.1007/s10067-024-07189-8. PubMed PMID:39422805 .
  2. Hao, Y, Hansen, D, Louthrenoo, W, Chen, YH, Cho, J, Lateef, A et al.. Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosus. Lupus Sci Med. 2024;11 (2):. doi: 10.1136/lupus-2024-001217. PubMed PMID:39299757 PubMed Central PMC11418568.
  3. Louthrenoo, W, Kasitanon, N, Wongthanee, A, Okudaira, Y, Takeuchi, A, Noguchi, H et al.. HLA Association among Thai Patients with Diffuse and Limited Cutaneous Systemic Sclerosis. Biomedicines. 2024;12 (6):. doi: 10.3390/biomedicines12061347. PubMed PMID:38927554 PubMed Central PMC11201995.
  4. Golder, V, Kandane-Rathnayake, R, Li, N, Louthrenoo, W, Chen, YH, Cho, J et al.. Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study. Lancet Rheumatol. 2024;6 (8):e528-e536. doi: 10.1016/S2665-9913(24)00121-8. PubMed PMID:38876129 .
  5. Kunlayawutipong, T, Rattanathammethee, T, Punnachet, T, Hantrakun, N, Piriyakhuntorn, P, Hantrakool, S et al.. Prevalence and risk factors for hyperuricemia and hyperuricosuria in patients with hematologic malignancies. Front Med (Lausanne). 2024;11 :1343000. doi: 10.3389/fmed.2024.1343000. PubMed PMID:38873194 PubMed Central PMC11169800.
  6. Na-Nan, K, Waisayanand, N, Gumtorntip, W, Wongthanee, A, Kasitanon, N, Louthrenoo, W et al.. Prevalence of thyroid dysfunctions and thyroid autoantibodies in Thai patients with systemic lupus erythematosus: An age- and sex-matched controlled study. Int J Rheum Dis. 2024;27 (5):e15195. doi: 10.1111/1756-185X.15195. PubMed PMID:38766699 .
  7. de Luca Montes, RA, Huq, M, Godfrey, T, Oon, S, Calderone, A, Kandane-Rathnayake, R et al.. Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study. Adv Rheumatol. 2024;64 (1):38. doi: 10.1186/s42358-024-00366-y. PubMed PMID:38720354 .
  8. Mongkolchaiarunya, J, Wongthanee, A, Kasitanon, N, Louthrenoo, W. Comparison of Clinical Features, Treatment and Outcomes of Lupus Nephritis Between Patients With Late- and Early-Onset Systemic Lupus Erythematosus: A Controlled Study. J Clin Med Res. 2024;16 (2-3):106-117. doi: 10.14740/jocmr5097. PubMed PMID:38550544 PubMed Central PMC10970043.
  9. Golder, V, Kandane-Rathnayake, R, Louthrenoo, W, Chen, YH, Cho, J, Lateef, A et al.. Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus. J Rheumatol. 2024;51 (8):790-797. doi: 10.3899/jrheum.2023-0900. PubMed PMID:38490668 .
  10. Katsumata, Y, Inoue, E, Harigai, M, Cho, J, Louthrenoo, W, Hoi, A et al.. Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study. Ann Rheum Dis. 2024;83 (8):998-1005. doi: 10.1136/ard-2023-225369. PubMed PMID:38423757 .
  11. Cho, J, Shen, L, Huq, M, Kandane-Rathnayake, R, Golder, V, Louthrenoo, W et al.. Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study. Lancet Rheumatol. 2023;5 (10):e584-e593. doi: 10.1016/S2665-9913(23)00209-6. PubMed PMID:38251484 .
  12. Jatuworapruk, K, Louthrenoo, W. Emerging therapeutic options for refractory gout. Nat Rev Rheumatol. 2024;20 (2):73-74. doi: 10.1038/s41584-023-01066-5. PubMed PMID:38102493 .
  13. Laosuksri, P, Phrintrakul, N, Gumtorntip, W, Na-Nan, K, Wongthanee, A, Kasitanon, N et al.. Non-loading versus loading low-dose colchicine in acute crystal-associated arthritis: A double-blinded randomized controlled study. Int J Rheum Dis. 2023;26 (12):2478-2488. doi: 10.1111/1756-185X.14943. PubMed PMID:37860923 .
  14. Mahakkanukrauh, A, Chaiamnuay, S, Koolvisoot, A, Kitamnuayphong, T, Manavathongchai, S, Osiri, M et al.. Safety and effectiveness of intravenous CT-P13 in inflammatory arthritis: post-marketing surveillance study in Thailand. Immunotherapy. 2023;15 (14):1143-1155. doi: 10.2217/imt-2022-0290. PubMed PMID:37589164 .
  15. Gumtorntip, W, Kasitanon, N, Louthrenoo, W, Chattipakorn, N, Chattipakorn, SC. Potential roles of air pollutants on the induction and aggravation of rheumatoid arthritis: From cell to bedside studies. Environ Pollut. 2023;334 :122181. doi: 10.1016/j.envpol.2023.122181. PubMed PMID:37453681 .
  16. Yeo, AL, Kandane-Rathnayake, R, Koelmeyer, R, Golder, V, Louthrenoo, W, Chen, YH et al.. SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus-an analysis of anti-double-stranded DNA monitoring. Rheumatology (Oxford). 2024;63 (2):525-533. doi: 10.1093/rheumatology/kead231. PubMed PMID:37208196 PubMed Central PMC10836977.
  17. Gumrai, P, Na-Nan, K, Tepsuwan, T, Suwannasom, P, Louthrenoo, W. Cardiac wall rupture in systemic lupus erythematosus: a case report and review of the literature. Clin Rheumatol. 2023;42 (8):2223-2229. doi: 10.1007/s10067-023-06614-8. PubMed PMID:37140686 .
  18. Mongkolchaiarunya, J, Wongthanee, A, Kasitanon, N, Louthrenoo, W. Comparison of clinical features, disease activity, treatment and outcomes between late-onset and early-onset patients with systemic lupus erythematosus. A sex- and year at diagnosis-matched controlled study. Adv Rheumatol. 2023;63 (1):20. doi: 10.1186/s42358-023-00297-0. PubMed PMID:37127712 .
  19. Dilokthornsakul, P, Sawangjit, R, Osiri, M, Chiowchanwisawakit, P, Louthrenoo, W, Permsuwan, U et al.. Cost-Utility Analysis of Biologic Disease-Modifying Antirheumatic Drugs for Patients With Psoriatic Arthritis in Thailand. Value Health Reg Issues. 2023;34 :40-47. doi: 10.1016/j.vhri.2022.10.005. PubMed PMID:36469988 .
  20. Connelly, K, Kandane-Rathnayake, R, Hoi, A, Louthrenoo, W, Hamijoyo, L, Cho, J et al.. Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study. Lancet Rheumatol. 2022;4 (12):e831-e841. doi: 10.1016/S2665-9913(22)00307-1. PubMed PMID:38261391 .
  21. Kandane-Rathnayake, R, Golder, V, Louthrenoo, W, Chen, YH, Cho, J, Lateef, A et al.. Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study. Lancet Rheumatol. 2022;4 (12):e822-e830. doi: 10.1016/S2665-9913(22)00304-6. PubMed PMID:38261390 .
  22. Connelly, K, Kandane-Rathnayake, R, Hoi, A, Louthrenoo, W, Hamijoyo, L, Luo, SF et al.. Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long-Term Clinical Outcomes: A Five-Year Prospective Study. Arthritis Rheumatol. 2023;75 (3):401-410. doi: 10.1002/art.42350. PubMed PMID:36122172 .
  23. Ketpueak, T, Chanloung, W, Nan, KN, Pongsananurak, C, Kasitanon, N, Louthrenoo, W et al.. Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma. Clin Rheumatol. 2022;41 (12):3887-3896. doi: 10.1007/s10067-022-06364-z. PubMed PMID:36085204 PubMed Central PMC9462648.
  24. Louthrenoo, W, Kasitanon, N, Wongthanee, A, Okudaira, Y, Takeuchi, M, Nakajima, F et al.. Association of HLA-DRB1*15:02:01, DQB1*05:01:24 and DPB1*13:01:01 in Thai patients with systemic sclerosis. HLA. 2022;100 (6):563-581. doi: 10.1111/tan.14793. PubMed PMID:36054790 .
  25. Winichakoon, P, Chanloung, W, Nantsupawat, T, Louthrenoo, W. Adult-Onset Still's Disease-like Syndrome following COVID-19 Vaccination: A Case Report and Review of the Literature. Vaccines (Basel). 2022;10 (7):. doi: 10.3390/vaccines10071022. PubMed PMID:35891186 PubMed Central PMC9317167.
  26. Piga, M, Chessa, E, Morand, EF, Ugarte-Gil, MF, Tektonidou, M, van Vollenhoven, R et al.. Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study. Lancet Rheumatol. 2022;4 (6):e441-e449. doi: 10.1016/S2665-9913(22)00107-2. PubMed PMID:38293958 .
  27. Piriyakhuntorn, P, Tantiworawit, A, Kasitanon, N, Louthrenoo, W. Prevalence and characteristics of inflammatory rheumatic diseases in patients with thalassemia. Ann Hematol. 2022;101 (8):1667-1675. doi: 10.1007/s00277-022-04870-3. PubMed PMID:35604471 .
  28. Phrintrakul, N, Wongthanee, A, Kasitanon, N, Louthrenoo, W. Translation, internal consistency, reliability and validity of the Thai version of Gout Assessment Questionnaire version 2.0 (GAQ 2.0). Clin Rheumatol. 2022;41 (7):2129-2141. doi: 10.1007/s10067-022-06148-5. PubMed PMID:35353262 .
  29. Likhit, O, Louthrenoo, W, Pattanakitsakul, SN, Suttitheptumrong, A, Hannongbua, S, Rungrotmongkol, T et al.. Determination of T Cell Responses in Thai Systemic Sclerosis Patients. J Immunol Res. 2022;2022 :5072154. doi: 10.1155/2022/5072154. PubMed PMID:35310606 PubMed Central PMC8924789.
  30. Kandane-Rathnayake, R, Louthrenoo, W, Hoi, A, Luo, SF, Wu, YJ, Chen, YH et al.. 'Not at target': prevalence and consequences of inadequate disease control in systemic lupus erythematosus-a multinational observational cohort study. Arthritis Res Ther. 2022;24 (1):70. doi: 10.1186/s13075-022-02756-3. PubMed PMID:35287720 PubMed Central PMC8919535.
  31. Ytterberg, SR, Bhatt, DL, Mikuls, TR, Koch, GG, Fleischmann, R, Rivas, JL et al.. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. N Engl J Med. 2022;386 (4):316-326. doi: 10.1056/NEJMoa2109927. PubMed PMID:35081280 .
  32. Louthrenoo, W, Trongkamolthum, T, Kasitanon, N, Wongthanee, A. Pregnancy outcomes between pregnant systemic lupus erythematosus patients with clinical remission and those with low disease activity: A comparative study. Arch Rheumatol. 2022;37 (3):361-374. doi: 10.46497/ArchRheumatol.2022.9140. PubMed PMID:36589601 PubMed Central PMC9791546.
  33. Lorenzo, JPP, Sollano, MHMZ, Salido, EO, Li-Yu, J, Tankeh-Torres, SA, Wulansari Manuaba, IAR et al.. 2021 Asia-Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout. Int J Rheum Dis. 2022;25 (1):7-20. doi: 10.1111/1756-185X.14266. PubMed PMID:34931463 .
  34. Chanloung, W, Kasitanon, N, Wichainun, R, Louthrenoo, W. Thrombotic risk assessment in patients with systemic lupus erythematosus: Validation of the adjusted-Global Antiphospholipid Syndrome Score (aGAPSS) in Thai patients. Int J Rheum Dis. 2021;24 (12):1510-1519. doi: 10.1111/1756-185X.14230. PubMed PMID:34716670 .
  35. Louthrenoo, W, Kasitanon, N, Wongthanee, A, Kuwata, S, Takeuchi, F. CTLA-4 polymorphisms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis. Int J Rheum Dis. 2021;24 (11):1378-1385. doi: 10.1111/1756-185X.14219. PubMed PMID:34533895 .
  36. Kandane-Rathnayake, R, Louthrenoo, W, Luo, SF, Wu, YJ, Chen, YH, Golder, V et al.. Patterns of Medication Use in Systemic Lupus Erythematosus: A Multicenter Cohort Study. Arthritis Care Res (Hoboken). 2022;74 (12):2033-2041. doi: 10.1002/acr.24740. PubMed PMID:34197023 .
  37. Louthrenoo, W, Kasitanon, N, Morand, E, Kandane-Rathnayake, R. Associations between physicians' global assessment of disease activity and patient-reported outcomes in patients with systemic lupus erythematosus: A longitudinal study. Lupus. 2021;30 (10):1586-1595. doi: 10.1177/09612033211027943. PubMed PMID:34192957 .
  38. Louthrenoo, W, Trongkamolthum, T, Kasitanon, N, Wongthanee, A. Disease Activity and Rate and Severity of Flares During Peripartum Period in Thai Patients With Systemic Lupus Erythematosus: An Age at Diagnosis and Disease Duration Matched Controlled Study. J Clin Rheumatol. 2022;28 (2):e473-e479. doi: 10.1097/RHU.0000000000001766. PubMed PMID:34176885 .
  39. Tam, LS, Tanaka, Y, Handa, R, Li, Z, Lorenzo, JP, Louthrenoo, W et al.. Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic. Int J Rheum Dis. 2021;24 (6):733-745. doi: 10.1111/1756-185X.14124. PubMed PMID:33945214 PubMed Central PMC8206920.
  40. Kandane-Rathnayake, R, Louthrenoo, W, Golder, V, Luo, SF, Wu, YJ, Lateef, A et al.. Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: a longitudinal, multinational study. Rheumatology (Oxford). 2021;60 (11):5185-5193. doi: 10.1093/rheumatology/keab217. PubMed PMID:33693676 PubMed Central PMC8566254.
  41. Louthrenoo, W, Trongkamolthum, T, Kasitanon, N, Wongthanee, A. Predicting factors of adverse pregnancy outcomes in Thai patients with systemic lupus erythematosus: A STROBE-compliant study. Medicine (Baltimore). 2021;100 (5):e24553. doi: 10.1097/MD.0000000000024553. PubMed PMID:33592909 PubMed Central PMC7870266.
  42. Wantaneeyawong, C, Kasitanon, N, Kumchana, K, Louthrenoo, W. Acute parkinsonism in patients with systemic lupus erythematosus: a case report and review of the literature. Int J Neurosci. 2022;132 (9):868-873. doi: 10.1080/00207454.2020.1847106. PubMed PMID:33153349 .
  43. Towiwat, P, Tangsumranjit, A, Ingkaninan, K, Jampachaisri, K, Chaichamnong, N, Buttham, B et al.. Effect of caffeinated and decaffeinated coffee on serum uric acid and uric acid clearance, a randomised within-subject experimental study. Clin Exp Rheumatol. 2021;39 (5):1003-1010. doi: 10.55563/clinexprheumatol/gd9nia. PubMed PMID:33025883 .
  44. Cho, J, Kandane-Rathnayake, R, Louthrenoo, W, Hoi, A, Golder, V, Chen, YH et al.. COVID-19 infection in patients with systemic lupus erythematosus: Data from the Asia Pacific Lupus Collaboration. Int J Rheum Dis. 2020;23 (9):1255-1257. doi: 10.1111/1756-185X.13937. PubMed PMID:32841510 PubMed Central PMC7461525.
  45. Jagpal, A, Rahn, EJ, Mudano, AS, Dalbeth, N, Taylor, W, Saag, KG et al.. Which factors predict discordance between a patient and physician on a gout flare?. Rheumatology (Oxford). 2021;60 (2):773-779. doi: 10.1093/rheumatology/keaa413. PubMed PMID:32793971 PubMed Central PMC10687509.
  46. Songsomboon, C, Tanprawate, S, Soontornpun, A, Wantaneeyawong, C, Louthrenoo, W. Serum Uric Acid, Serum Uric Acid to Serum Creatinine Ratio and Serum Bilirubin in Patients With Parkinson's Disease: A Case-Control Study. J Clin Med Res. 2020;12 (3):172-179. doi: 10.14740/jocmr4079. PubMed PMID:32231753 PubMed Central PMC7092755.
  47. Louthrenoo, W, Kasitanon, N, Pathanapitoon, K, Wangkaew, S, Kuwata, S, Nishi, A et al.. Contribution of HLA-B*51:01 and -A*26:01 to Behçet's disease and their clinical association in Thai patients. Int J Rheum Dis. 2020;23 (2):247-255. doi: 10.1111/1756-185X.13785. PubMed PMID:31944588 .
  48. Louthrenoo, W, Kasitanon, N, Morand, E, Kandane-Rathnayake, R. Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythematosus: a longitudinal study. Arthritis Res Ther. 2020;22 (1):8. doi: 10.1186/s13075-020-2095-4. PubMed PMID:31924267 PubMed Central PMC6954627.
  49. Apostolopoulos, D, Kandane-Rathnayake, R, Louthrenoo, W, Luo, SF, Wu, YJ, Lateef, A et al.. Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study. Lancet Rheumatol. 2020;2 (1):e24-e30. doi: 10.1016/S2665-9913(19)30105-5. PubMed PMID:38258272 .
  50. Kandane-Rathnayake, R, Kent, JR, Louthrenoo, W, Luo, SF, Wu, YJ, Lateef, A et al.. Longitudinal associations of active renal disease with irreversible organ damage accrual in systemic lupus erythematosus. Lupus. 2019;28 (14):1669-1677. doi: 10.1177/0961203319887799. PubMed PMID:31718467 .
  51. Golder, V, Kandane-Rathnayake, R, Huq, M, Nim, HT, Louthrenoo, W, Luo, SF et al.. Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study. Lancet Rheumatol. 2019;1 (2):e95-e102. doi: 10.1016/S2665-9913(19)30037-2. PubMed PMID:38229349 .
  52. Golder, V, Kandane-Rathnayake, R, Huq, M, Louthrenoo, W, Luo, SF, Wu, YJ et al.. Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study. Lancet Rheumatol. 2019;1 (2):e103-e110. doi: 10.1016/S2665-9913(19)30048-7. PubMed PMID:38229337 .
  53. Bursill, D, Taylor, WJ, Terkeltaub, R, Abhishek, A, So, AK, Vargas-Santos, AB et al.. Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout. Ann Rheum Dis. 2019;78 (11):1592-1600. doi: 10.1136/annrheumdis-2019-215933. PubMed PMID:31501138 PubMed Central PMC7288724.
  54. Louthrenoo, W, Nilganuwong, S, Nanagara, R, Siripaitoon, B, Collaud Basset, S. Diacerein for the treatment of rheumatoid arthritis in patients with inadequate response to methotrexate: a pilot randomized, double-blind, placebo-controlled add-on trial. Clin Rheumatol. 2019;38 (9):2461-2471. doi: 10.1007/s10067-019-04587-1. PubMed PMID:31104217 .
  55. Lau, CS, Chia, F, Dans, L, Harrison, A, Hsieh, TY, Jain, R et al.. 2018 update of the APLAR recommendations for treatment of rheumatoid arthritis. Int J Rheum Dis. 2019;22 (3):357-375. doi: 10.1111/1756-185X.13513. PubMed PMID:30809944 .
  56. Chaloemwong, J, Tantiworawit, A, Rattanathammethee, T, Chai-Adisaksopha, C, Rattarittamrong, E, Norasetthada, L et al.. Hyperuricemia, urine uric excretion, and associated complications in thalassemia patients. Ann Hematol. 2019;98 (5):1101-1110. doi: 10.1007/s00277-019-03630-0. PubMed PMID:30721337 .
  57. Kandane-Rathnayake, R, Golder, V, Louthrenoo, W, Luo, SF, Jan Wu, YJ, Li, Z et al.. Development of the Asia Pacific Lupus Collaboration cohort. Int J Rheum Dis. 2019;22 (3):425-433. doi: 10.1111/1756-185X.13431. PubMed PMID:30398013 .
  58. Bursill, D, Taylor, WJ, Terkeltaub, R, Kuwabara, M, Merriman, TR, Grainger, R et al.. Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout. Arthritis Care Res (Hoboken). 2019;71 (3):427-434. doi: 10.1002/acr.23607. PubMed PMID:29799677 PubMed Central PMC6252290.
  59. Chiowchanwisawakit, P, Katchamart, W, Osiri, M, Narongroeknawin, P, Chevaisrakul, P, Kitumnuaypong, T et al.. Effectiveness and Drug Survival of Anti-Tumor Necrosis Factor α Therapies in Patients With Spondyloarthritis: Analysis From the Thai Rheumatic Disease Prior Authorization Registry. J Clin Rheumatol. 2019;25 (1):9-15. doi: 10.1097/RHU.0000000000000741. PubMed PMID:29517554 .
  60. Gaffo, AL, Dalbeth, N, Saag, KG, Singh, JA, Rahn, EJ, Mudano, AS et al.. Brief Report: Validation of a Definition of Flare in Patients With Established Gout. Arthritis Rheumatol. 2018;70 (3):462-467. doi: 10.1002/art.40381. PubMed PMID:29161469 .
  61. Damrongpipatkul, U, Oranratanachai, K, Kasitanon, N, Wuttiplakorn, S, Louthrenoo, W. Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study. Clin Rheumatol. 2018;37 (3):691-702. doi: 10.1007/s10067-017-3892-2. PubMed PMID:29103182 .
  62. Mease, PJ, Jeka, S, Jaller, JJ, Kitumnuaypong, T, Louthrenoo, W, Mann, H et al.. CNTO6785, a Fully Human Antiinterleukin 17 Monoclonal Antibody, in Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate: A Randomized, Placebo-controlled, Phase II, Dose-ranging Study. J Rheumatol. 2018;45 (1):22-31. doi: 10.3899/jrheum.161238. PubMed PMID:29093159 .
  63. Kasitanon, N, Boripatkosol, P, Louthrenoo, W. Response to combination of mycophenolate mofetil, cyclosporin A and corticosteroid treatment in lupus nephritis patients with persistent proteinuria. Int J Rheum Dis. 2018;21 (1):200-207. doi: 10.1111/1756-185X.13152. PubMed PMID:28901731 .
  64. Louthrenoo, W, Kasitanon, N, Katchamart, W, Aiewruengsurat, D, Chevaisrakul, P, Chiowchanwisawakit, P et al.. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Int J Rheum Dis. 2017;20 (9):1166-1184. doi: 10.1111/1756-185X.13130. PubMed PMID:28730640 .
  65. Jatuworapruk, K, Kattipathanapong, T, Kasitanon, N, Louthrenoo, W. Ergotism Masquerading Systemic Vasculitis. J Clin Rheumatol. 2017;23 (5):287-288. doi: 10.1097/RHU.0000000000000523. PubMed PMID:28661928 .
  66. Louthrenoo, W, Jatuworapruk, K, Lhakum, P, Pattamapaspong, N. Performance of the 2015 American College of Rheumatology/European League Against Rheumatism gout classification criteria in Thai patients. Rheumatol Int. 2017;37 (5):705-711. doi: 10.1007/s00296-017-3708-3. PubMed PMID:28349197 .
  67. Golder, V, Kandane-Rathnayake, R, Hoi, AY, Huq, M, Louthrenoo, W, An, Y et al.. Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study. Arthritis Res Ther. 2017;19 (1):62. doi: 10.1186/s13075-017-1256-6. PubMed PMID:28320433 PubMed Central PMC5359963.
  68. Pattamapaspong, N, Vuthiwong, W, Kanthawang, T, Louthrenoo, W. Value of ultrasonography in the diagnosis of gout in patients presenting with acute arthritis. Skeletal Radiol. 2017;46 (6):759-767. doi: 10.1007/s00256-017-2611-z. PubMed PMID:28275814 .
  69. Wangkaew, S, Suwansirikul, S, Aroonrungwichian, K, Kasitanon, N, Louthrenoo, W. The Correlation of Muscle Biopsy Scores with the Clinical Variables in Idiopathic Inflammatory Myopathies. Open Rheumatol J. 2016;10 :141-149. doi: 10.2174/1874312901610010141. PubMed PMID:28144368 PubMed Central PMC5220170.
  70. GEO-RA Group. Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey. Clin Rheumatol. 2017;36 (3):485-497. doi: 10.1007/s10067-016-3481-9. PubMed PMID:27995382 .
  71. Golder, V, Kandane-Rathnayake, R, Hoi, AY, Huq, M, Louthrenoo, W, An, Y et al.. Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort. Arthritis Res Ther. 2016;18 (1):260. doi: 10.1186/s13075-016-1163-2. PubMed PMID:27829463 PubMed Central PMC5103412.
  72. Dalbeth, N, Schumacher, HR, Fransen, J, Neogi, T, Jansen, TL, Brown, M et al.. Survey Definitions of Gout for Epidemiologic Studies: Comparison With Crystal Identification as the Gold Standard. Arthritis Care Res (Hoboken). 2016;68 (12):1894-1898. doi: 10.1002/acr.22896. PubMed PMID:27014846 .
  73. Ogdie, A, Taylor, WJ, Neogi, T, Fransen, J, Jansen, TL, Schumacher, HR et al.. Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard. Arthritis Rheumatol. 2017;69 (2):429-438. doi: 10.1002/art.39959. PubMed PMID:27748084 PubMed Central PMC5278908.
  74. Wangkaew, S, Sivasomboon, C, Leungwatthananon, W, Kasitanon, N, Louthrenoo, W. Prevalence and predictors of hand involvement in Thai patients with systemic sclerosis. Int J Rheum Dis. 2018;21 (1):240-248. doi: 10.1111/1756-185X.12919. PubMed PMID:27456855 .
  75. Katchamart, W, Narongroeknawin, P, Chevaisrakul, P, Dechanuwong, P, Mahakkanukrauh, A, Kasitanon, N et al.. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association. Int J Rheum Dis. 2017;20 (9):1142-1165. doi: 10.1111/1756-185X.12905. PubMed PMID:27452207 .
  76. Kanthawang, T, Pattamapaspong, N, Louthrenoo, W. Acute bone infarction: a rare complication in thalassemia. Skeletal Radiol. 2016;45 (7):1013-6. doi: 10.1007/s00256-016-2387-6. PubMed PMID:27105620 .
  77. Jatuworapruk, K, Lhakum, P, Pattamapaspong, N, Kasitanon, N, Wangkaew, S, Louthrenoo, W et al.. Performance of the Existing Classification Criteria for Gout in Thai Patients Presenting With Acute Arthritis. Medicine (Baltimore). 2016;95 (5):e2730. doi: 10.1097/MD.0000000000002730. PubMed PMID:26844519 PubMed Central PMC4748936.
  78. Lhakum, P, Kasitanon, N, Sivasomboon, C, Wangkaew, S, Louthrenoo, W. Deforming Arthropathy in Thai Patients With Systemic Lupus Erythematosus. J Clin Rheumatol. 2016;22 (1):1-7. doi: 10.1097/RHU.0000000000000333. PubMed PMID:26693619 .
  79. Taylor, WJ, Fransen, J, Dalbeth, N, Neogi, T, Ralph Schumacher, H, Brown, M et al.. Diagnostic Arthrocentesis for Suspicion of Gout Is Safe and Well Tolerated. J Rheumatol. 2016;43 (1):150-3. doi: 10.3899/jrheum.150684. PubMed PMID:26628602 .
  80. Wangkaew, S, Euathrongchit, J, Wattanawittawas, P, Kasitanon, N, Louthrenoo, W. Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: Inception cohort study. Mod Rheumatol. 2016;26 (4):588-93. doi: 10.3109/14397595.2015.1115455. PubMed PMID:26561397 .
  81. Franklyn, K, Lau, CS, Navarra, SV, Louthrenoo, W, Lateef, A, Hamijoyo, L et al.. Definition and initial validation of a Lupus Low Disease Activity State (LLDAS). Ann Rheum Dis. 2016;75 (9):1615-21. doi: 10.1136/annrheumdis-2015-207726. PubMed PMID:26458737 .
  82. Mease, PJ, McInnes, IB, Kirkham, B, Kavanaugh, A, Rahman, P, van der Heijde, D et al.. Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis. N Engl J Med. 2015;373 (14):1329-39. doi: 10.1056/NEJMoa1412679. PubMed PMID:26422723 .
  83. de Lautour, H, Taylor, WJ, Adebajo, A, Alten, R, Burgos-Vargas, R, Chapman, P et al.. Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises. Arthritis Care Res (Hoboken). 2016;68 (5):667-72. doi: 10.1002/acr.22741. PubMed PMID:26414176 .
  84. Louthrenoo, W, Hongsongkiat, S, Kasitanon, N, Wangkaew, S, Jatuworapruk, K. Effect of Antituberculous Drugs on Serum Uric Acid and Urine Uric Acid Excretion. J Clin Rheumatol. 2015;21 (7):346-8. doi: 10.1097/RHU.0000000000000297. PubMed PMID:26398460 .
  85. Louthrenoo, W. Treatment considerations in patients with concomitant viral infection and autoimmune rheumatic diseases. Best Pract Res Clin Rheumatol. 2015;29 (2):319-42. doi: 10.1016/j.berh.2015.05.010. PubMed PMID:26362747 .
  86. Lau, CS, Chia, F, Harrison, A, Hsieh, TY, Jain, R, Jung, SM et al.. APLAR rheumatoid arthritis treatment recommendations. Int J Rheum Dis. 2015;18 (7):685-713. doi: 10.1111/1756-185X.12754. PubMed PMID:26334449 .
  87. Taylor, WJ, Fransen, J, Jansen, TL, Dalbeth, N, Schumacher, HR, Brown, M et al.. Study for Updated Gout Classification Criteria: Identification of Features to Classify Gout. Arthritis Care Res (Hoboken). 2015;67 (9):1304-1315. doi: 10.1002/acr.22585. PubMed PMID:25777045 PubMed Central PMC4573373.
  88. Louthrenoo, W, Kasitanon, N, Wangkaew, S, Kuwata, S, Takeuchi, F. Distribution of HLA-DR alleles among Thai patients with rheumatoid arthritis. Hum Immunol. 2015;76 (2-3):113-7. doi: 10.1016/j.humimm.2015.01.018. PubMed PMID:25636569 .
  89. Taylor, WJ, Fransen, J, Dalbeth, N, Neogi, T, Schumacher, HR, Brown, M et al.. Performance of classification criteria for gout in early and established disease. Ann Rheum Dis. 2016;75 (1):178-82. doi: 10.1136/annrheumdis-2014-206364. PubMed PMID:25351521 .
  90. Wangkaew, S, Euathrongchit, J, Patiwetwitoon, S, Prasertwitayakij, N, Kasitanon, N, Louthrenoo, W et al.. The relevance of high-resolution computed tomographic findings and pulmonary arterial hypertension in systemic sclerosis-associated interstitial lung disease. J Med Assoc Thai. 2014;97 (8):878-85. . PubMed PMID:25345265 .
  91. Kasitanon, N, Intaniwet, T, Wangkaew, S, Pantana, S, Sukitawut, W, Louthrenoo, W et al.. The clinically quiescent phase in early-diagnosed SLE patients: inception cohort study. Rheumatology (Oxford). 2015;54 (5):868-75. doi: 10.1093/rheumatology/keu406. PubMed PMID:25339640 .
  92. Wangkaew, S, Kasitanon, N, Hongsongkiat, S, Tanasombat, C, Sukittawut, W, Louthrenoo, W et al.. A comparative study of serum and synovial fluid levels of uric acid between patients with gout and other arthritides. J Med Assoc Thai. 2014;97 (7):679-85. . PubMed PMID:25265764 .
  93. Louthrenoo, W. An insight into rheumatology in Thailand. Nat Rev Rheumatol. 2015;11 (1):55-61. doi: 10.1038/nrrheum.2014.142. PubMed PMID:25201382 .
  94. Jatuworapruk, K, Srichairatanakool, S, Ounjaijean, S, Kasitanon, N, Wangkaew, S, Louthrenoo, W et al.. Effects of green tea extract on serum uric acid and urate clearance in healthy individuals. J Clin Rheumatol. 2014;20 (6):310-3. doi: 10.1097/RHU.0000000000000148. PubMed PMID:25160013 .
  95. Khantisopon, N, Louthrenoo, W, Kasitanon, N, Sivasomboon, C, Wangkaew, S, Sang-In, S et al.. Periodontal disease in Thai patients with rheumatoid arthritis. Int J Rheum Dis. 2014;17 (5):511-8. doi: 10.1111/1756-185X.12315. PubMed PMID:24581320 .
  96. Louthrenoo, W, Kasitanon, N, Wangkaew, S, Hongsongkiat, S, Sukitawut, W, Wichainun, R et al.. Streptococcus agalactiae: an emerging cause of septic arthritis. J Clin Rheumatol. 2014;20 (2):74-8. doi: 10.1097/RHU.0000000000000071. PubMed PMID:24561409 .
  97. Wichainun, R, Kasitanon, N, Wangkaew, S, Hongsongkiat, S, Sukitawut, W, Louthrenoo, W et al.. Sensitivity and specificity of ANA and anti-dsDNA in the diagnosis of systemic lupus erythematosus: a comparison using control sera obtained from healthy individuals and patients with multiple medical problems. Asian Pac J Allergy Immunol. 2013;31 (4):292-8. doi: 10.12932/AP0272.31.4.2013. PubMed PMID:24383972 .
  98. Kasitanon, N, Achsavalertsak, U, Maneeton, B, Wangkaew, S, Puntana, S, Sukitawut, W et al.. Associated factors and psychotherapy on sleep disturbances in systemic lupus erythematosus. Lupus. 2013;22 (13):1353-60. doi: 10.1177/0961203313507355. PubMed PMID:24080701 .
  99. Pulido, T, Adzerikho, I, Channick, RN, Delcroix, M, Galiè, N, Ghofrani, HA et al.. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med. 2013;369 (9):809-18. doi: 10.1056/NEJMoa1213917. PubMed PMID:23984728 .
  100. Maneeton, B, Maneeton, N, Louthrenoo, W. Prevalence and predictors of depression in patients with systemic lupus erythematosus: a cross-sectional study. Neuropsychiatr Dis Treat. 2013;9 :799-804. doi: 10.2147/NDT.S44248. PubMed PMID:23766649 PubMed Central PMC3678948.
  101. Lertchaisataporn, K, Kasitanon, N, Wangkaew, S, Pantana, S, Sukitawut, W, Louthrenoo, W et al.. An evaluation of the association of leukopenia and severe infection in patients with systemic lupus erythematosus. J Clin Rheumatol. 2013;19 (3):115-20. doi: 10.1097/RHU.0b013e318289bb9b. PubMed PMID:23519174 .
  102. Prowse, RL, Dalbeth, N, Kavanaugh, A, Adebajo, AO, Gaffo, AL, Terkeltaub, R et al.. A delphi exercise to identify characteristic features of gout - opinions from patients and physicians, the first stage in developing new classification criteria. J Rheumatol. 2013;40 (4):498-505. doi: 10.3899/jrheum.121037. PubMed PMID:23418379 .
  103. Louthrenoo, W, Kasitanon, N, Wichainun, R, Wangkaew, S, Sukitawut, W, Ohnogi, Y et al.. Association of HLA-DRB1*15:02 and DRB5*01:02 allele with the susceptibility to systemic sclerosis in Thai patients. Rheumatol Int. 2013;33 (8):2069-77. doi: 10.1007/s00296-013-2686-3. PubMed PMID:23404077 .
  104. Kasitanon, N, Wangkaew, S, Puntana, S, Sukitawut, W, Leong, KP, Tan Tock Seng Hospital Lupus Study Group et al.. The reliability, validity and responsiveness of the Thai version of Systemic Lupus Erythematosus Quality of Life (SLEQOL-TH) instrument. Lupus. 2013;22 (3):289-96. doi: 10.1177/0961203312474702. PubMed PMID:23358871 .
  105. Louthrenoo, W, Kasitanon, N, Wichainun, R, Wangkaew, S, Sukitawut, W, Ohnogi, Y et al.. The genetic contribution of HLA-DRB5*01:01 to systemic lupus erythematosus in Thailand. Int J Immunogenet. 2013;40 (2):126-30. doi: 10.1111/j.1744-313X.2012.01145.x. PubMed PMID:22862923 .
  106. Patiwetwitoon, S, Wangkaew, S, Euathrongchit, J, Kasitanon, N, Louthrenoo, W. High-resolution computed tomographic findings in systemic sclerosis-associated interstitial lung disease: comparison between diffuse and limited systemic sclerosis. J Clin Rheumatol. 2012;18 (5):229-33. doi: 10.1097/RHU.0b013e318261176f. PubMed PMID:22832288 .
  107. Pattamapaspong, N, Louthrenoo, W. Musculoskeletal infection in acquired immunodeficiency syndrome. Semin Musculoskelet Radiol. 2011;15 (5):541-53. doi: 10.1055/s-0031-1293499. PubMed PMID:22081288 .
  108. Jakes, RW, Bae, SC, Louthrenoo, W, Mok, CC, Navarra, SV, Kwon, N et al.. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res (Hoboken). 2012;64 (2):159-68. doi: 10.1002/acr.20683. PubMed PMID:22052624 .
  109. Louthrenoo, W, Kasitanon, N, Wichainun, R, Wangkaew, S, Sukitawut, W, Ohnogi, Y et al.. Lack of CTGF*-945C/G Dimorphism in Thai Patients with Systemic Sclerosis. Open Rheumatol J. 2011;5 :59-63. doi: 10.2174/1874312901105010059. PubMed PMID:22046208 PubMed Central PMC3204428.
  110. Toworakul, C, Kasitanon, N, Sukitawut, W, Wichinun, R, Louthrenoo, W. Usefulness of pleural effusion antinuclear antibodies in the diagnosis of lupus pleuritis. Lupus. 2011;20 (10):1042-6. doi: 10.1177/0961203311402531. PubMed PMID:21659420 .
  111. Chotayaporn, T, Kasitanon, N, Sukitawut, W, Louthrenoo, W. Comparison of proteinuria determination by urine dipstick, spot urine protein creatinine index, and urine protein 24 hours in lupus patients. J Clin Rheumatol. 2011;17 (3):124-9. doi: 10.1097/RHU.0b013e318214bd18. PubMed PMID:21441821 .
  112. Maneeton, B, Maneeton, N, Louthrenoo, W. Cognitive deficit in patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol. 2010;28 (1):77-83. . PubMed PMID:20527520 .
  113. Rubbert-Roth, A, Tak, PP, Zerbini, C, Tremblay, JL, Carreño, L, Armstrong, G et al.. Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR). Rheumatology (Oxford). 2010;49 (9):1683-93. doi: 10.1093/rheumatology/keq116. PubMed PMID:20463186 PubMed Central PMC2919195.
  114. Louthrenoo, W, Kasitanon, N, Wichainun, R, Wangkaew, S, Sukitawut, W, Kuwata, S et al.. Anti-agalactosyl IgG antibodies in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis. Clin Rheumatol. 2010;29 (3):241-6. doi: 10.1007/s10067-009-1284-y. PubMed PMID:20091076 .
  115. Kasitanon, N, Sukitawut, W, Louthrenoo, W. Acute rheumatic fever in adults: case report together with an analysis of 25 patients with acute rheumatic fever. Rheumatol Int. 2009;29 (9):1041-5. doi: 10.1007/s00296-008-0796-0. PubMed PMID:19043714 .
  116. Wangkaew, S, Kasitanon, N, Phrommintikul, A, Sukitawut, W, Wichainun, R, Louthrenoo, W et al.. Pulmonary arterial hypertension in Thai patients with systemic sclerosis. J Med Assoc Thai. 2008;91 (2):166-72. . PubMed PMID:18389980 .
  117. Louthrenoo, W. Rheumatic manifestations of human immunodeficiency virus infection. Curr Opin Rheumatol. 2008;20 (1):92-9. doi: 10.1097/BOR.0b013e3282f1fea7. PubMed PMID:18281864 .
  118. Taylor, WJ, Schumacher, HR Jr, Baraf, HS, Chapman, P, Stamp, L, Doherty, M et al.. A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout. Ann Rheum Dis. 2008;67 (6):888-91. doi: 10.1136/ard.2007.079970. PubMed PMID:18055475 .
  119. Narata, R, Wangkaew, S, Kasitanon, N, Louthrenoo, W. Community-acquired pneumonia in Thai patients with systemic lupus erythematosus. Southeast Asian J Trop Med Public Health. 2007;38 (3):528-36. . PubMed PMID:17877230 .
  120. Mongkoltanatus, J, Wangkaew, S, Kasitanon, N, Louthrenoo, W. Clinical features of Thai male lupus: an age-matched controlled study. Rheumatol Int. 2008;28 (4):339-44. doi: 10.1007/s00296-007-0442-2. PubMed PMID:17828538 .
  121. Ungprasert, S, Wangkaew, S, Louthrenoo, W. Physician's awareness of the prevention of corticosteroid induced osteoporosis. J Med Assoc Thai. 2007;90 (1):59-64. . PubMed PMID:17621734 .
  122. Leecharoen, S, Wangkaew, S, Louthrenoo, W. Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma. J Med Assoc Thai. 2007;90 (1):52-8. . PubMed PMID:17621733 .
  123. Athisakul, S, Wangkaew, S, Louthrenoo, W. Inappropriate prescription of allopurinol in a teaching hospital. J Med Assoc Thai. 2007;90 (5):889-94. . PubMed PMID:17596042 .
  124. Louthrenoo, W, Nilganuwong, S, Aksaranugraha, S, Asavatanabodee, P, Saengnipanthkul, S, Thai Study Group et al.. The efficacy, safety and carry-over effect of diacerein in the treatment of painful knee osteoarthritis: a randomised, double-blind, NSAID-controlled study. Osteoarthritis Cartilage. 2007;15 (6):605-14. doi: 10.1016/j.joca.2007.02.021. PubMed PMID:17448700 .
  125. Wangkaew, S, Kasitanon, N, Sivasomboon, C, Wichainun, R, Sukitawut, W, Louthrenoo, W et al.. Sicca symptoms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma: a comparison with age-matched controls and correlation with disease variables. Asian Pac J Allergy Immunol. 2006;24 (4):213-21. . PubMed PMID:17348244 .
  126. Louthrenoo, W, Kasitanon, N, Wichainun, R, Sukitawut, W. Effect of minidose aspirin on renal function and renal uric acid handling in healthy young adults. J Clin Rheumatol. 2002;8 (6):299-304. doi: 10.1097/00124743-200212000-00003. PubMed PMID:17041398 .
  127. Louthrenoo, W, Aramsareewong, T, Sukitawut, W. Adult onset Still's disease: clinical features and outcome in 16 Thai patients. J Clin Rheumatol. 2001;7 (5):301-7. doi: 10.1097/00124743-200110000-00009. PubMed PMID:17039160 .
  128. Kasitanon, N, Louthrenoo, W, Wangkaew, S, Sukitawut, W, Wichainun, R. Validation of the Thai version of a screening questionnaire for detection of systemic lupus erythematosus. J Med Assoc Thai. 2006;89 (4):448-52. . PubMed PMID:16696388 .
  129. Pothacharoen, P, Teekachunhatean, S, Louthrenoo, W, Yingsung, W, Ong-Chai, S, Hardingham, T et al.. Raised chondroitin sulfate epitopes and hyaluronan in serum from rheumatoid arthritis and osteoarthritis patients. Osteoarthritis Cartilage. 2006;14 (3):299-301. doi: 10.1016/j.joca.2005.10.005. PubMed PMID:16309927 .
  130. Vanittanakom, N, Supabandhu, J, Khamwan, C, Praparattanapan, J, Thirach, S, Prasertwitayakij, N et al.. Identification of emerging human-pathogenic Pythium insidiosum by serological and molecular assay-based methods. J Clin Microbiol. 2004;42 (9):3970-4. doi: 10.1128/JCM.42.9.3970-3974.2004. PubMed PMID:15364977 PubMed Central PMC516349.
  131. Prasertwitayakij, N, Louthrenoo, W, Kasitanon, N, Thamprasert, K, Vanittanakom, N. Human pythiosis, a rare cause of arteritis: case report and literature review. Semin Arthritis Rheum. 2003;33 (3):204-14. doi: 10.1016/j.semarthrit.2003.09.003. PubMed PMID:14671729 .
  132. Louthrenoo, W, Kasitanon, N, Sukitawut, W, Wichainun, R. A clinical study of crystal-proven gouty arthritis in a university hospital. J Med Assoc Thai. 2003;86 (9):868-75. . PubMed PMID:14649972 .
  133. Louthrenoo, W, Kasitanon, N, Mahanuphab, P, Bhoopat, L, Thongprasert, S. Kaposi's sarcoma in rheumatic diseases. Semin Arthritis Rheum. 2003;32 (5):326-33. doi: 10.1053/sarh.2002.50000. PubMed PMID:12701043 .
  134. Kasitanon, N, Louthrenoo, W, Piyasirisilp, S, Sukitawu, W, Wichainun, R. Neuropsychiatric manifestations in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol. 2002;20 (3):179-85. . PubMed PMID:12587842 .
  135. Louthrenoo, W, Lertprasertsuke, N, Kasitanon, N, Sukitawut, W. Erythema nodosum as a manifestation of HIV infection. Asian Pac J Allergy Immunol. 2002;20 (3):175-8. . PubMed PMID:12587841 .
  136. Ruangjutipopan, S, Kasitanon, N, Louthrenoo, W, Sukitawut, W, Wichainun, R. Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis. J Med Assoc Thai. 2002;85 (11):1204-9. . PubMed PMID:12546318 .
  137. Ausayakhun, S, Louthrenoo, W, Aupapong, S. Ocular diseases in patients with rheumatic diseases. J Med Assoc Thai. 2002;85 (8):855-62. . PubMed PMID:12403205 .
  138. Kasitanon, N, Louthrenoo, W, Sukitawut, W, Vichainun, R. Causes of death and prognostic factors in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol. 2002;20 (2):85-91. . PubMed PMID:12403192 .
  139. Louthrenoo, W, Weerayutwattana, N, Lertprasertsuke, N, Sukitawut, W. Serum muscle enzymes, muscle pathology and clinical muscle weakness: correlation in Thai patients with polymyositis/dermatomyositis. J Med Assoc Thai. 2002;85 (1):26-32. . PubMed PMID:12075717 .
  140. Louthrenoo, W, Kongtawelert, P, Sivasomboon, C, Sukitawut, W. Correlation between serum hyaluronan and disease activity and severity in Thai patients with rheumatoid arthritis. J Med Assoc Thai. 2001;84 (5):622-7. . PubMed PMID:11560209 .
  141. Louthrenoo, W, Kasitanon, N, Sukitawut, W. Arthritis in leukemia. J Clin Rheumatol. 2000;6 (6):313-7. doi: 10.1097/00124743-200012000-00002. PubMed PMID:19078491 .
  142. Khongsaengdao, B, Louthrenoo, W, Srisurapanont, M. Depression in Thai patients with rheumatoid arthritis. J Med Assoc Thai. 2000;83 (7):743-7. . PubMed PMID:10932508 .
  143. Louthrenoo, W, Kanjanavanit, R, Sukitawut, W. Acute aortic valvulitis as an initial presentation of systemic lupus erythematosus. Asian Pac J Allergy Immunol. 1999;17 (2):121-4. . PubMed PMID:10466548 .
  144. Sittiwangkul, S, Louthrenoo, W, Vithayasai, P, Sukitawut, W. Pregnancy outcome in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol. 1999;17 (2):77-83. . PubMed PMID:10466542 .
  145. Louthrenoo, W, Sukitawut, W. Calcium pyrophosphate dihydrate crystal deposition: a clinical and laboratory analysis of 91 Thai patients. J Med Assoc Thai. 1999;82 (6):569-76. . PubMed PMID:10443078 .
  146. Louthrenoo, W, Norasetthada, A, Khunamornpong, S, Sreshthaputra, A, Sukitawut, W. Childhood Churg-Strauss syndrome. J Rheumatol. 1999;26 (6):1387-93. . PubMed PMID:10381061 .
  147. Louthrenoo, W, Ruttanaumpawan, P, Aramrattana, A, Sukitawut, W. Cardiovascular autonomic nervous system dysfunction in patients with rheumatoid arthritis and systemic lupus erythematosus. QJM. 1999;92 (2):97-102. doi: 10.1093/qjmed/92.2.97. PubMed PMID:10209661 .
  148. Louthrenoo, W, Sukitawut, W. A clinical study of Thai patients with spondyloarthropathy. J Med Assoc Thai. 1998;81 (12):986-92. . PubMed PMID:9916388 .
  149. Manorot, M, Rojanasathien, N, Louthrenoo, W, Tonsuwannont, W, Teekachunhatean, S. Comparative studies of quality and bioavailability of methotrexate in Thai patients with rheumatoid arthritis. J Med Assoc Thai. 1998;81 (12):978-85. . PubMed PMID:9916387 .
  150. Lau, CS, Burgos-Vargas, R, Louthrenoo, W, Mok, MY, Wordsworth, P, Zeng, QY et al.. Features of spondyloarthritis around the world. Rheum Dis Clin North Am. 1998;24 (4):753-70. doi: 10.1016/s0889-857x(05)70040-5. PubMed PMID:9891709 .
  151. Louthrenoo, W, Boonyaratavej, S, Sittiwangkul, R, Sukitawut, W. Anti Ro/SSA positive undifferentiated connective tissue disease in a mother with a newborn with complete congenital heart block: a case report. J Med Assoc Thai. 1998;81 (8):633-6. . PubMed PMID:9737117 .
  152. Louthrenoo, W. Reply. J Clin Rheumatol. 1998;4 (2):106. doi: 10.1097/00124743-199804000-00017. PubMed PMID:19078265 .
  153. Olivé, A, Pérez-Andrés, R, Tena, X, Louthrenoo, W. Musculoskeletal Manifestations of HIV Infection. J Clin Rheumatol. 1998;4 (2):105. doi: 10.1097/00124743-199804000-00016. PubMed PMID:19078263 .
  154. Louthrenoo, W, Ojarasporn, W, Norasetthada, A, Sukitawut, W. Ruptured mycotic abdominal aortic aneurysm in a patient with systemic lupus erythematosus. J Clin Rheumatol. 1998;4 (1):36-8. doi: 10.1097/00124743-199802000-00008. PubMed PMID:19078242 .
  155. Louthrenoo, W. Musculoskeletal Manifestations of HIV Infection in Thailand: An Analysis of 100 Cases. J Clin Rheumatol. 1997;3 (5):258-68. doi: 10.1097/00124743-199710000-00004. PubMed PMID:19078199 .
  156. Levin, RW, Park, J, Ostrov, B, Reginato, A, Baker, DG, Bomalaski, JS et al.. Clinical assessment of the 1987 American College of Rheumatology criteria for rheumatoid arthritis. Scand J Rheumatol. 1996;25 (5):277-81. doi: 10.3109/03009749609104058. PubMed PMID:8921919 .
  157. Louthrenoo, W. Disseminated penicillinase-producing Neisseria gonorrhoeae in a patient infected with human immunodeficiency virus. Br J Rheumatol. 1995;34 (5):487-8. doi: 10.1093/rheumatology/34.5.487. PubMed PMID:7788189 .
  158. Louthrenoo, W, Thamprasert, K, Sirisanthana, T. Osteoarticular penicilliosis marneffei. A report of eight cases and review of the literature. Br J Rheumatol. 1994;33 (12):1145-50. doi: 10.1093/rheumatology/33.12.1145. PubMed PMID:8000744 .
  159. Louthrenoo, W, Mahanuphab, P, Sanguanmitra, P, Thamprasert, K. Trichinosis mimicking polymyositis in a patient with human immunodeficiency virus infection. Br J Rheumatol. 1993;32 (11):1025-6. doi: 10.1093/rheumatology/32.11.1025. PubMed PMID:8220926 .
  160. Louthrenoo, W. Salmonella septic arthritis in patients with human immunodeficiency virus infection. J Rheumatol. 1993;20 (8):1454-5. . PubMed PMID:8230049 .
  161. Louthrenoo, W. Successful treatment of severe Reiter's syndrome associated with human immunodeficiency virus infection with etretinate. Report of 2 cases. J Rheumatol. 1993;20 (7):1243-6. . PubMed PMID:8371230 .
  162. Louthrenoo, W, Zager, EL, Freundlich, B, Zurier, RB. Intravenous corticosteroid therapy of cervical cord compression in rheumatoid arthritis. Clin Exp Rheumatol. 1992;10 (2):173-5. . PubMed PMID:1505111 .
  163. Boonsaner, K, Louthrenoo, W, Meyer, S, Schumacher, HR Jr. Effect of dominancy on severity in rheumatoid arthritis. Br J Rheumatol. 1992;31 (2):77-80. doi: 10.1093/rheumatology/31.2.77. PubMed PMID:1737234 .
  164. Louthrenoo, W, Ostrov, BE, Park, YS, Rothfuss, S, Schumacher, HR Jr. Pseudoseptic arthritis: an unusual presentation of neuropathic arthropathy. Ann Rheum Dis. 1991;50 (10):717-21. doi: 10.1136/ard.50.10.717. PubMed PMID:1958097 PubMed Central PMC1004539.
  165. Louthrenoo, W, Sieck, M, Clayburne, G, Rothfuss, S, Schumacher, HR Jr. Supravital staining of cells in noninflammatory synovial fluids: analysis of the effect of crystals on cell populations. J Rheumatol. 1991;18 (3):409-13. . PubMed PMID:1713271 .
  166. Louthrenoo, W, Abrahm, J, Schumacher, HR Jr. Hemarthrosis in patients with acquired factor VIII inhibitor. J Rheumatol. 1991;18 (1):104-5. . PubMed PMID:1902518 .
  167. Louthrenoo, W, Park, YS, Philippe, L, Schumacher, HR Jr. Localized peripheral calcium oxalate crystal deposition caused by Aspergillus niger infection. J Rheumatol. 1990;17 (3):407-12. . PubMed PMID:2185361 .
  168. Louthrenoo, W, Schumacher, HR Jr. Listeria monocytogenes osteomyelitis complicating leukemia: report and literature review of Listeria osteoarticular infections. J Rheumatol. 1990;17 (1):107-10. . PubMed PMID:2179548 .
Search PubMed